Invention Grant
US08771697B2 Methods of treatment using anti-IL-17A/IL-17F cross-reactive antibodies
有权
使用抗IL-17A / IL-17F交叉反应抗体的治疗方法
- Patent Title: Methods of treatment using anti-IL-17A/IL-17F cross-reactive antibodies
- Patent Title (中): 使用抗IL-17A / IL-17F交叉反应抗体的治疗方法
-
Application No.: US13492280Application Date: 2012-06-08
-
Publication No.: US08771697B2Publication Date: 2014-07-08
- Inventor: Krzysztof Masternak , Olivier Leger
- Applicant: Krzysztof Masternak , Olivier Leger
- Applicant Address: CH Geneva
- Assignee: Novimmune SA
- Current Assignee: Novimmune SA
- Current Assignee Address: CH Geneva
- Agency: Arnold & Porter LLP
- Agent Ginger R. Dreger
- Main IPC: A61K39/395
- IPC: A61K39/395
Abstract:
This invention provides fully human monoclonal antibodies that recognize IL-17F, the IL-17F homodimer, IL-17A, the IL-17A homodimer, and/or the heterodimeric IL-17A/IL-17F protein complex. The invention further provides methods of using such monoclonal antibodies as a therapeutic, diagnostic, and prophylactic.
Public/Granted literature
- US20120269820A1 ANTI-IL 17A/IL-17F CROSS-REACTIVE ANTIBODIES AND METHODS OF USE THEREOF Public/Granted day:2012-10-25
Information query
